State of the Art Photon Therapy Versus Particle Therapy for Recurrent Head & Neck Tumors; a Planning Study
Condition: Carcinoma, Squamous Cell of Head and NeckInterventions: Radiation: Photon therapy versus proton therapy; Radiation: Photon therapy versus C-ion therapySponsors: Maastricht Radiation Oncology; University of Pennsylvania; Philipps University Marburg Medical Center; University Medical Center NijmegenRecruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2014 Category: Research Source Type: clinical trials
State of the Art Photon Therapy Versus Particle Therapy for Recurrent Head & Neck Tumors; a Planning Study
Condition: Carcinoma, Squamous Cell of Head and NeckInterventions: Radiation: Photon therapy versus proton therapy; Radiation: Photon therapy versus C-ion therapySponsors: Maastricht Radiation Oncology; University of Pennsylvania; Philipps University Marburg Medical Center; University Medical Center NijmegenRecruiting - verified August 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2014 Category: Research Source Type: clinical trials
State of the Art Photon Therapy Versus Particle Therapy for Recurrent Head & Neck Tumors; a Planning Study
Condition: Carcinoma, Squamous Cell of Head and NeckInterventions: Radiation: Photon therapy versus proton therapy; Radiation: Photon therapy versus C-ion therapySponsors: Maastricht Radiation Oncology; University of Pennsylvania; Philipps University Marburg Medical Center; University Medical Center NijmegenRecruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2014 Category: Research Source Type: clinical trials
State of the Art Photon Therapy Versus Particle Therapy for Recurrent Head & Neck Tumors; a Planning Study
Condition: Carcinoma, Squamous Cell of Head and NeckInterventions: Radiation: Photon therapy versus proton therapy; Radiation: Photon therapy versus C-ion therapySponsors: Maastricht Radiation Oncology; University of Pennsylvania; Philipps University Marburg Medical Center; University Medical Center NijmegenRecruiting - verified August 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2014 Category: Research Source Type: clinical trials
State of the Art Photon Therapy Versus Particle Therapy for Recurrent Head & Neck Tumors; a Planning Study
Condition: Carcinoma, Squamous Cell of Head and NeckInterventions: Radiation: Photon therapy versus proton therapy; Radiation: Photon therapy versus C-ion therapySponsors: Maastricht Radiation Oncology; University of Pennsylvania; Philipps University Marburg Medical Center; University Medical Center NijmegenRecruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2014 Category: Research Source Type: clinical trials
Pharmacological Conditioning of Sleep Patterns in Healthy Participants Using Amitriptylin
Condition: Healthy ParticipantsInterventions: Drug: Amitriptyline; Drug: PlaceboSponsors: Winfried Rief; Philipps University Marburg Medical CenterCompleted - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2014 Category: Research Source Type: clinical trials
Expectations and Side Effects of Endocrine Therapy in Women With Breast Cancer
Condition: Female Breast CancerIntervention: Behavioral: Enhanced information about endocrine therapySponsor: Philipps University Marburg Medical CenterActive, not recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2014 Category: Research Source Type: clinical trials
Comparison of Continuous Femoral Nerve Block and Adductor Canal Block After Total Knee Replacement Therapy
Conditions: Total Knee Arthroplasty; Total Knee Replacement; Femoral Nerve Block; Adductor Canal BlockIntervention: Drug: RopivacaineSponsor: Philipps University Marburg Medical CenterRecruiting - verified April 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2014 Category: Research Source Type: clinical trials
